Condition · Hormones
Hormone optimisation
Evidence hub for hormone optimisation and related biohacking interventions.
01
Evidence-ranked peptides
| Peptide | Use | Evidence |
|---|---|---|
| Tesamorelin Tesamorelin is a regulated peptide medicine with established evidence in defined indications. | discussed_or_researched_for low_to_review | Human5/5 Animal0/5 Safety4/5 4 verified refs |
| Kisspeptin Kisspeptin is an endogenous signalling peptide with physiological relevance; therapeutic administration remains molecule- and indication-specific. | Hormone optimisation weak | Human3/5 Animal0/5 Safety3/5 3 verified refs |
| Sermorelin Sermorelin is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | discussed_or_researched_for low_to_review | Human1/5 Animal0/5 Safety0/5 1 verified ref |
| Neurokinin B Neurokinin B is an endogenous signalling peptide with physiological relevance; therapeutic administration remains molecule- and indication-specific. | Hormone optimisation insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Testagen Testagen is an organ-associated short peptide promoted for regulatory effects, but independent modern clinical evidence is sparse. | Hormone optimisation insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Phoenixin Phoenixin is an endogenous signalling peptide with established or emerging physiological relevance. | Hormone optimisation insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
02
Current standard management
conventional medicineEvidence-based non-peptide options — including exercise, sleep, nutrition, physiotherapy and licensed medical treatments — often have stronger human evidence than research peptides.
Medical disclaimer —Standard-of-care information is educational only. Do not change or start treatment based on Atlas content. Always consult a qualified clinician for personal medical decisions.
04
Linked mechanisms
biological pathways discussed for this condition- HPG axis modulationlimited
- Sensory neuropeptide modulationlimited
- Inflammation modulationlimited
03
Community observations
No approved community reports for this condition yet. Submit one.
Clinician discussion
Questions you can ask a qualified clinician
- What are the established evidence-based options for this condition?
- What monitoring is appropriate before considering any experimental intervention?
- What long-term safety data exists for peptide-based approaches?
- Are there licensed medicines relevant to my situation?
↳
Explore further
from the knowledge graphPeptides that touch this